Use App
Trending
News
Earnings
All
DIA
0.17%
SPY
0.21%
QQQ
0.29%
Trending
AMZN
0.39%
NIO
3.92%
IROHA
23.23%
AAPL
0.17%
NBIS
2.43%
META
0.44%
MSFT
0.01%
PLTR
0.43%
NVDA
0.82%
FJET
4.55%
AMZN
0.39%
NIO
3.92%
IROHA
23.23%
AAPL
0.17%
NBIS
2.43%
META
0.44%
MSFT
0.01%
PLTR
0.43%
NVDA
0.82%
FJET
4.55%
home
Symbol
CNSP
news
CNSP
Cns Pharmaceuticals Inc
7,756
Mkt Cap
$1.77M
Volume
38,570.00
52W High
$34.80
52W Low
$2.06
PE Ratio
-0.05
CNSP Fundamentals
Price
$2.18
Prev Close
$2.18
Open
$2.34
50D MA
$3.31
Beta
1.05
Avg. Volume
46,893.32
EPS (Annual)
-$35.75
P/B
0.30
Rev/Employee
$0.00
$4.54
PE Ratio
-0.05
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
11mo ago
Full Article
<
...
1
>
Latest CNSP News
View
Advertisement
|
Remove ads.
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile